pharmaverse/aNCA
Feb 2025 – Oct 2025
8 Months active
Languages Used
RR MarkdownTextCSVJavaScriptRoxygen
Technical Skills
Code FormattingCode formattingData FormattingData ManipulationData TransformationDocumentation
Aspridis
PROFILE
Aspridis
Alex Spridil developed and maintained core features for the pharmaverse/aNCA repository, focusing on pharmacokinetic data processing and quality control visualization. Over eight months, Alex standardized data models, improved data ingestion and transformation pipelines, and enhanced Shiny-based user interfaces for interactive QC plots. Using R, Shiny, and ggplot2, Alex refactored code for maintainability, introduced robust error handling, and implemented advanced filtering and plotting capabilities. The work included rigorous documentation, comprehensive testing, and careful release management, resulting in a more reliable, traceable, and user-friendly analysis workflow. Alex’s contributions strengthened data integrity and streamlined the package’s ongoing development and onboarding.
Overall Statistics
Feature vs Bugs
66%Features
Repository Contributions
90Total
Bugs
13
Commits
90
Features
25
Lines of code
5,541
Activity Months8
Your Network
20 peopleSame Organization
@emea.roche.com2
Work History
October 2025
2 Commits • 1 Features
Oct 1, 2025October 2025 performance summary for pharmaverse/aNCA: Delivered reliability improvements to the NCA workflow and standardized internal data processing to enhance maintainability and user experience. The changes are small, low-risk, but have measurable impact on robustness and consistency across calculations.
2 Commits • 1 Features
Oct 1, 2025October 2025 performance summary for pharmaverse/aNCA: Delivered reliability improvements to the NCA workflow and standardized internal data processing to enhance maintainability and user experience. The changes are small, low-risk, but have measurable impact on robustness and consistency across calculations.
October 2025
September 2025
13 Commits • 1 Features
Sep 1, 2025Summary for 2025-09: Delivered a significantly enhanced QC visualization experience in pharmaverse/aNCA, introducing a new QC Plot tab with interactive, faceted visualizations; improved performance for QC plot generation and PKNCA object creation; ensured robust parameter handling for QC features; completed rigorous linting, testing, and documentation enhancements; and tightened UI/UX for tooltips and color controls. These efforts improved data quality assessment speed and reliability, enabling faster, more accurate decision-making for quality control analyses.
September 2025
13 Commits • 1 Features
Sep 1, 2025Summary for 2025-09: Delivered a significantly enhanced QC visualization experience in pharmaverse/aNCA, introducing a new QC Plot tab with interactive, faceted visualizations; improved performance for QC plot generation and PKNCA object creation; ensured robust parameter handling for QC features; completed rigorous linting, testing, and documentation enhancements; and tightened UI/UX for tooltips and color controls. These efforts improved data quality assessment speed and reliability, enabling faster, more accurate decision-making for quality control analyses.
August 2025
10 Commits • 3 Features
Aug 1, 2025August 2025 monthly summary for pharmaverse/aNCA: Focused on delivering robust data processing for faceted QC plots, standardizing dose-related data handling, and housekeeping to enable a release. Improvements reduced ambiguity in data processing, increased test reliability, and strengthened the repository’s readiness for production deployment.
10 Commits • 3 Features
Aug 1, 2025August 2025 monthly summary for pharmaverse/aNCA: Focused on delivering robust data processing for faceted QC plots, standardizing dose-related data handling, and housekeeping to enable a release. Improvements reduced ambiguity in data processing, increased test reliability, and strengthened the repository’s readiness for production deployment.
August 2025
July 2025
30 Commits • 12 Features
Jul 1, 2025July 2025 — Pharmaverse/aNCA: Strengthened reliability and usability through targeted bug fixes, new functionality, and quality improvements. Delivered tooltip text generation, PK-plot customization, and a new functionality file, expanded tests and documentation, and improved packaging readiness for smoother maintenance and faster feature delivery.
July 2025
30 Commits • 12 Features
Jul 1, 2025July 2025 — Pharmaverse/aNCA: Strengthened reliability and usability through targeted bug fixes, new functionality, and quality improvements. Delivered tooltip text generation, PK-plot customization, and a new functionality file, expanded tests and documentation, and improved packaging readiness for smoother maintenance and faster feature delivery.
June 2025
5 Commits • 1 Features
Jun 1, 2025June 2025 monthly summary for pharmaverse/aNCA highlighting key feature delivery, bug fixes, and overall impact. Demonstrated strong data ingestion UX improvements in a Shiny app, coupled with rigorous documentation and code quality efforts.
5 Commits • 1 Features
Jun 1, 2025June 2025 monthly summary for pharmaverse/aNCA highlighting key feature delivery, bug fixes, and overall impact. Demonstrated strong data ingestion UX improvements in a Shiny app, coupled with rigorous documentation and code quality efforts.
June 2025
April 2025
10 Commits • 3 Features
Apr 1, 2025April 2025 (pharmaverse/aNCA) Monthly Summary Focused on data quality, feature completeness, and release hygiene. Delivered clear, business-value features, fixed data-mersistence naming inconsistencies, and prepared a stable minor release with updated documentation.
April 2025
10 Commits • 3 Features
Apr 1, 2025April 2025 (pharmaverse/aNCA) Monthly Summary Focused on data quality, feature completeness, and release hygiene. Delivered clear, business-value features, fixed data-mersistence naming inconsistencies, and prepared a stable minor release with updated documentation.
March 2025
10 Commits • 3 Features
Mar 1, 2025Concise monthly summary for 2025-03 focused on delivering features, stabilizing workflow, and standardizing data terms in pharmaverse/aNCA. Emphasizes business value, maintainability, and technical excellence.
10 Commits • 3 Features
Mar 1, 2025Concise monthly summary for 2025-03 focused on delivering features, stabilizing workflow, and standardizing data terms in pharmaverse/aNCA. Emphasizes business value, maintainability, and technical excellence.
March 2025
February 2025
10 Commits • 1 Features
Feb 1, 2025February 2025 (2025-02) monthly summary for pharmaverse/aNCA. Focused on delivering standardized pharmacokinetic routing and robust data formatting to improve downstream analytics and reproducibility. Implemented a dedicated standard route column (std_route) with INTRAVASCULAR and EXTRAVASCULAR values, and ensured robust route handling across format_pkncaconc_data and dose creation. Enhanced data integrity by explicit mapping to the mydata pipeline and by passing route_column explicitly during df_dose creation. Updated output tables to include ROUTE, enabling clearer traceability from source data to PK metrics. Updated documentation and man pages to reflect the new interface and data model. Major bugs fixed: Release version bump 0.0.0.9007, incrementing package version for release management with no functional changes. Overall impact and accomplishments: Strengthened PK data integrity and reproducibility, enabling more reliable analyses and reporting. The changes improve data traceability, reduce risk of misclassification of routes, and support maintainable pipelines. Documentation, tests (where applicable), and release hygiene have been improved to support long-term stability and onboarding of new contributors. Technologies/skills demonstrated: Data wrangling and feature engineering in R, explicit function interface design, mapping and data lineage, code quality improvements (style and documentation), and release management.
February 2025
10 Commits • 1 Features
Feb 1, 2025February 2025 (2025-02) monthly summary for pharmaverse/aNCA. Focused on delivering standardized pharmacokinetic routing and robust data formatting to improve downstream analytics and reproducibility. Implemented a dedicated standard route column (std_route) with INTRAVASCULAR and EXTRAVASCULAR values, and ensured robust route handling across format_pkncaconc_data and dose creation. Enhanced data integrity by explicit mapping to the mydata pipeline and by passing route_column explicitly during df_dose creation. Updated output tables to include ROUTE, enabling clearer traceability from source data to PK metrics. Updated documentation and man pages to reflect the new interface and data model. Major bugs fixed: Release version bump 0.0.0.9007, incrementing package version for release management with no functional changes. Overall impact and accomplishments: Strengthened PK data integrity and reproducibility, enabling more reliable analyses and reporting. The changes improve data traceability, reduce risk of misclassification of routes, and support maintainable pipelines. Documentation, tests (where applicable), and release hygiene have been improved to support long-term stability and onboarding of new contributors. Technologies/skills demonstrated: Data wrangling and feature engineering in R, explicit function interface design, mapping and data lineage, code quality improvements (style and documentation), and release management.
Activity
Loading activity data...
Quality Metrics
Correctness91.6%
Maintainability92.2%
Architecture88.8%
Performance86.2%
AI Usage20.0%
Skills & Technologies
Programming Languages
CSVJavaScriptRR MarkdownRoxygenText
Technical Skills
Bug FixingCode FormattingCode LintingCode MaintenanceCode RefactoringCode StyleCode formattingConfigurationData AnalysisData CleaningData FilteringData FormattingData ManagementData ManipulationData Mapping
Repositories Contributed To
Overview of all repositories you've contributed to across your timeline